News

Researchers have identified seven combination therapies that are superior to courses of single antibiotics for treating persistent Lyme disease in mice. The laboratory study, published in the peer-reviewed journal Frontiers in Microbiology, was conducted by Bay Area Lyme... Read More »

A message from the Center for Lyme Action: Dear Lyme Advocate: Congratulations to all Lyme advocates for your work to grow federal funding for Lyme and tick-borne disease!  We are making our journey through the Fiscal Year 2024 appropriations process. Let’s keep it going!... Read More »

By Cameron Langford, Courthouse News Service Patients who were denied coverage for their long-term Lyme disease cannot hold an infectious disease society liable for its medical opinion that there is no convincing evidence of the existence of chronic Lyme disease, a Fifth Circuit... Read More »

As of Jan. 1, 2024, IGeneX will no longer offer the Western blot test for Lyme disease. It will be replaced by the ImmunBlot. The company says the ImmunoBlot differs from the Western blot in two key ways. “First, it looks for multiple pathogens, instead of one with the... Read More »

by Emily Caldwell, Ohio State News A species of exotic tick arrived in Ohio in 2021 in such huge numbers that their feeding frenzy on a southeastern farm left three cattle dead of what researchers believe was severe blood loss. The scientists from The Ohio State University have... Read More »

Invisible International, a non-profit organization that offers online training for health practitioners and the public, has released a new course on “Racial Disparities in Lyme Disease.” It sheds light on the significant gaps in healthcare that contribute to the... Read More »

Bay Area Lyme Foundation has announced the development of a potential new drug, HS-291, that targets and destroys Borrelia burgdorferi, the bacterium that causes Lyme disease. Published in the peer-reviewed journal Cell Chemical Biology, this laboratory study represents a... Read More »

By Julie Rafferty, Tufts University Scientists at Tufts University School of Medicine and the Graduate School of Biomedical Sciences (GSBS) have developed a genome-scale metabolic model or “subway map” of key metabolic activities of the bacterium that causes Lyme disease. Using... Read More »

In the period 2018-2022, more Lyme disease claim lines were filed for individuals in the 51-60 age group than any other group, according to an infographic based on private insurance claims and released today by FAIR Health.1 Individuals aged 51 to 60 accounted for 23.5 percen... Read More »